On Dec. 20, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved BRAFTOVI® (encorafenib)…
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
May 4, 2018, scientists from the National Cancer Institute (NCI) reported that an analysis of a prevention clinical…
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
In 2003, two randomized controlled trials showed that taking aspirin daily for as little as three years reduces…
On Nov. 19, 1999, National Colorectal Cancer Awareness Month was established with a declaration by the U.S. Senate,…
On Dec. 2, 1993, Dana-Farber scientists identified the gene that causes an inherited form of colon cancer, which…
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched The trial was designed to determine whether…
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…